RU2004111357A - Комбинированные агенты для лечения глаукомы - Google Patents
Комбинированные агенты для лечения глаукомы Download PDFInfo
- Publication number
- RU2004111357A RU2004111357A RU2004111357/15A RU2004111357A RU2004111357A RU 2004111357 A RU2004111357 A RU 2004111357A RU 2004111357/15 A RU2004111357/15 A RU 2004111357/15A RU 2004111357 A RU2004111357 A RU 2004111357A RU 2004111357 A RU2004111357 A RU 2004111357A
- Authority
- RU
- Russia
- Prior art keywords
- treatment
- prevention
- combination
- glaucoma
- glaucoma according
- Prior art date
Links
- 0 *Cc(cc1)ccc1-c(cccc1)c1-c1nnn[n]1 Chemical compound *Cc(cc1)ccc1-c(cccc1)c1-c1nnn[n]1 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Claims (10)
1. Комбинация для профилактики или лечения глаукомы, которая включает антагонист ангиотензина II и простагландинов в качестве активных ингредиентов, для одновременного, раздельного или последовательного использования указанных активных ингредиентов, где антагонист ангиотензина II представляет собой соединение формулы (I) или его фармакологически приемлемую соль, сложный эфир или другое производное:
где R1 представляет группу, имеющую структурную формулу (Ia), (Ib), (Ic), (Id), (Ie) или (If):
2. Комбинация для профилактики или лечения глаукомы по п. 1, в которой R1 представляет группу, имеющую формулу (Ia), (Ib) или (Ic).
3. Комбинация для профилактики или лечения глаукомы по п. 1, в которой R1 представляет группу, имеющую формулу (Ia).
4. Комбинация для профилактики или лечения глаукомы по любому из пп. 1-3, в которой простагландин представляет собой изопропил унопростон или латанопрост или их фармацевтически приемлемую соль.
5. Комбинация для профилактики или лечения глаукомы по любому из пп. 1-3, в которой простагландин представляет собой изопропил унопростон или латанопрост.
6. Комбинация для профилактики или лечения глаукомы по любому из пп. 1-3, которая находится в форме, удобной для местного нанесения в глаза.
7. Комбинация для профилактики или лечения глаукомы по любому из п. 4, которая находится в форме, удобной для местного нанесения в глаза.
8. Комбинация для профилактики или лечения глаукомы по любому из п. 5, которая находится в форме, удобной для местного нанесения в глаза.
10. Способ профилактики или лечения глаукомы, который включает введение пациенту комбинации для профилактики или лечения глаукомы по любому из пп. 1-9.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP34152499 | 1999-12-01 | ||
JP11/341524 | 1999-12-01 | ||
JP2000-78769 | 2000-03-21 | ||
JP2000078769 | 2000-03-21 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2002114335/15A Division RU2002114335A (ru) | 1999-12-01 | 2000-12-01 | Комбинированные агенты для лечения глаукомы |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2004111357A true RU2004111357A (ru) | 2005-09-20 |
RU2299067C2 RU2299067C2 (ru) | 2007-05-20 |
Family
ID=26576988
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2002114335/15A RU2002114335A (ru) | 1999-12-01 | 2000-12-01 | Комбинированные агенты для лечения глаукомы |
RU2004111359/15A RU2004111359A (ru) | 1999-12-01 | 2004-04-13 | Комбинированные агенты для лечения глаукомы |
RU2004111358/15A RU2004111358A (ru) | 1999-12-01 | 2004-04-13 | Комбинированные агенты для лечения глаукомы |
RU2004111357/15A RU2299067C2 (ru) | 1999-12-01 | 2004-04-13 | Комбинированные агенты для лечения глаукомы |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2002114335/15A RU2002114335A (ru) | 1999-12-01 | 2000-12-01 | Комбинированные агенты для лечения глаукомы |
RU2004111359/15A RU2004111359A (ru) | 1999-12-01 | 2004-04-13 | Комбинированные агенты для лечения глаукомы |
RU2004111358/15A RU2004111358A (ru) | 1999-12-01 | 2004-04-13 | Комбинированные агенты для лечения глаукомы |
Country Status (22)
Country | Link |
---|---|
US (4) | US7307096B2 (ru) |
EP (3) | EP1344535A3 (ru) |
JP (1) | JP4000505B2 (ru) |
KR (3) | KR20040045029A (ru) |
CN (3) | CN1263512C (ru) |
AT (1) | ATE332145T1 (ru) |
AU (1) | AU773110B2 (ru) |
BR (1) | BR0015980A (ru) |
CA (1) | CA2392804C (ru) |
CZ (1) | CZ20021829A3 (ru) |
DE (1) | DE60029242T2 (ru) |
ES (1) | ES2267586T3 (ru) |
HK (1) | HK1047239B (ru) |
HU (1) | HUP0204049A3 (ru) |
IL (2) | IL149444A0 (ru) |
MX (1) | MXPA02005505A (ru) |
NO (1) | NO20022584L (ru) |
NZ (1) | NZ518930A (ru) |
PL (1) | PL201783B1 (ru) |
RU (4) | RU2002114335A (ru) |
TW (1) | TWI290470B (ru) |
WO (1) | WO2001039805A1 (ru) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0209063A (pt) * | 2001-04-19 | 2004-08-10 | Teika Pharmaceutical Co Ltd | Medicamentos e kits de uso medicinal |
TW200305424A (en) | 2002-01-29 | 2003-11-01 | Santen Pharmaceutical Co Ltd | Glaucoma-treating agent comprising bunazosin and prostaglandin |
US20050119299A1 (en) * | 2002-03-08 | 2005-06-02 | Sankyo Company, Limited | Ophthalmic solutions containing tetrazole derivatives |
US8580851B2 (en) | 2002-08-21 | 2013-11-12 | Sucampo Ag | Ophthalmic solution |
US7074827B2 (en) * | 2002-10-24 | 2006-07-11 | Sucampo Ag (Usa) Inc. | Method for treating ocular hypertension and glaucoma |
EP2404606A1 (en) * | 2003-08-21 | 2012-01-11 | Sucampo AG | Ophthalmic compositions comprising a prostaglandin and a viscosity agent |
WO2005079809A1 (ja) * | 2004-02-19 | 2005-09-01 | Santen Pharmaceutical Co., Ltd. | 澄明なラタノプロスト点眼液 |
JP2005263792A (ja) * | 2004-02-19 | 2005-09-29 | Santen Pharmaceut Co Ltd | 澄明なラタノプロスト点眼液 |
CN101400354B (zh) * | 2006-03-13 | 2014-10-22 | 株式会社·R-技术上野 | 水性组合物 |
US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
CN102970973A (zh) * | 2010-05-07 | 2013-03-13 | 太阳医药高级研发有限公司 | 新型眼用组合物 |
RU2443416C2 (ru) * | 2010-05-17 | 2012-02-27 | Республиканское Унитарное производственное предприятие "Белмедпрепараты" | Капли глазные |
WO2012100347A1 (en) * | 2011-01-24 | 2012-08-02 | Inceptum Research & Therapeutics, Inc. | Compositions comprising a prostaglandin for treating neuropsychiatric conditions |
KR101327267B1 (ko) | 2012-04-26 | 2013-11-11 | 한양대학교 에리카산학협력단 | 엔드이펙터용 구동력 전달장치 |
CA2968926C (en) * | 2014-11-25 | 2023-01-17 | Izhar Halahmi | Compositions and methods for delivering a bio-active agent or bio-active agents |
WO2016093346A1 (ja) * | 2014-12-12 | 2016-06-16 | 興和株式会社 | 水性組成物 |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3619370A (en) | 1969-04-21 | 1971-11-09 | Frosst & Co Charles E | Microbial reduction of thiadiazoles |
JPS4966691A (ru) | 1972-10-30 | 1974-06-27 | ||
IE50901B1 (en) * | 1980-03-04 | 1986-08-06 | Merck & Co Inc | Ophthalmic compositions of carbonic anhydrase inhibitors for topical application in the treatment of elevated intraocular pressure |
US4394382A (en) | 1980-06-17 | 1983-07-19 | Kowa Company, Ltd. | Dihydrobenzopyran compounds and pharmaceutical composition comprising said compounds |
US4863922A (en) | 1984-12-12 | 1989-09-05 | Merck & Co., Inc. | Substituted aromatic sulfonamides as antiglaucoma agents, compositions and use |
DE3568431D1 (en) * | 1984-12-12 | 1989-04-06 | Merck & Co Inc | Substituted aromatic sulfonamides, their preparation and ophthalmic compositions containing them |
US5182264A (en) * | 1986-03-07 | 1993-01-26 | Schering Corporation | Angiotensin II receptor blockers as antiglaucoma agents |
JP2610619B2 (ja) * | 1987-07-22 | 1997-05-14 | エーザイ株式会社 | 高眼圧症治療用点眼剤 |
JPS6426518U (ru) | 1987-08-11 | 1989-02-15 | ||
ES2213504T1 (es) | 1988-09-06 | 2004-09-01 | Pfizer Health Ab | Derivados de prostaglandina para el tratamiento del glaucoma o hipertension ocular. |
WO1990002533A2 (de) | 1988-09-09 | 1990-03-22 | Klaus Draenert | Hüftgelenksprothese und ihre verwendung |
EP0375299A1 (en) * | 1988-12-19 | 1990-06-27 | Merck & Co. Inc. | Combinations of angiotensin converting enzyme, and carbonic anhydrase, inhibitors for treating glaucoma |
US5273976A (en) * | 1989-04-06 | 1993-12-28 | Sankyo Company, Limited | Ocular hypotensive agents |
US5175161A (en) * | 1989-04-06 | 1992-12-29 | Sankyo Company, Limited | Occular hypotensive agents |
WO1991015206A1 (en) * | 1990-04-05 | 1991-10-17 | E.I. Du Pont De Nemours And Company | Treatment of glaucoma and ocular hypertension with imidazole angiotensin-ii receptor antagonists |
CA2057089A1 (en) * | 1990-12-07 | 1992-06-08 | Eric E. Allen | Substituted pyrazolopyrimidines and imidazopyridazines as angiotensin ii antagonists |
US5250521A (en) | 1990-12-07 | 1993-10-05 | Merck & Co., Inc. | Substituted pyrazolopyrimidines as angiotensin II antagonists |
NZ242724A (en) * | 1991-05-15 | 1994-09-27 | Du Pont | Synergistic composition comprising an angiotensin-ii receptor antagonist and a calcium channel blocker |
IL104648A0 (en) | 1992-02-13 | 1993-06-10 | Merck & Co Inc | Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a prostaglandin or prostaglandin derivative |
DK0625903T3 (da) * | 1992-02-21 | 1999-05-10 | Alcon Lab Inc | Topiske antiglaukompræparater omfattende carbonsyreanhydraseinhibitorer og beta-blokkere |
CA2125251C (en) * | 1993-06-07 | 2005-04-26 | Yoshiyuki Inada | A pharmaceutical composition for angiotensin ii-mediated diseases |
CZ154994A3 (en) * | 1993-07-02 | 1995-09-13 | Senju Pharma Co | Visual hypotensive agent |
US5510383A (en) * | 1993-08-03 | 1996-04-23 | Alcon Laboratories, Inc. | Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension |
CA2181461A1 (en) * | 1994-02-08 | 1995-08-17 | Alica Huxley | Treatment of normotensive glaucoma with angiotensin ii antagonists |
RU2123847C1 (ru) * | 1994-03-16 | 1998-12-27 | Санкио Компани Лимитед | Лекарственное средство и способ лечения повышенного глазного давления и/или глаукомы |
CA2185524C (en) * | 1994-03-16 | 2006-12-05 | Tomihisa Yokoyama | Ocular tension depressant |
US5760249A (en) * | 1995-08-29 | 1998-06-02 | Merck & Co., Inc. | Synthesis of hydroxysulfone and related compounds |
US5741810A (en) | 1996-02-29 | 1998-04-21 | Allergan | Cyclopentane heptan(ene)oic acid, 2- heteroarylalkenyl derivatives as therapeutic agents |
KR19990087076A (ko) * | 1996-04-05 | 1999-12-15 | 다께다 구니오 | 안지오텐신 ⅱ 및 길항 활성을 갖는 화합물을 함유하는 약제학적 배합물 |
AR002194A1 (es) * | 1997-03-17 | 1998-01-07 | Sanchez Reynaldo Alemany | Instrumento computarizado para el analisis del movimiento. |
US6037368A (en) | 1997-05-09 | 2000-03-14 | Mount Sinai School Of Medicine | 8-iso- prostaglandins for glaucoma therapy |
PL200009B1 (pl) * | 1999-06-11 | 2008-11-28 | Sankyo Co | Kompozycja obniżająca ciśnienie wewnątrzgałkowe oraz zastosowanie antagonisty angiotensyny II do obniżania ciśnienia wewnątrzgałkowego |
-
2000
- 2000-11-30 JP JP2000363933A patent/JP4000505B2/ja not_active Expired - Fee Related
- 2000-11-30 TW TW089125460A patent/TWI290470B/zh not_active IP Right Cessation
- 2000-12-01 PL PL355431A patent/PL201783B1/pl not_active IP Right Cessation
- 2000-12-01 AT AT00978074T patent/ATE332145T1/de not_active IP Right Cessation
- 2000-12-01 KR KR10-2004-7004652A patent/KR20040045029A/ko not_active Application Discontinuation
- 2000-12-01 DE DE60029242T patent/DE60029242T2/de not_active Expired - Fee Related
- 2000-12-01 CN CNB008166668A patent/CN1263512C/zh not_active Expired - Fee Related
- 2000-12-01 WO PCT/JP2000/008545 patent/WO2001039805A1/ja active IP Right Grant
- 2000-12-01 IL IL14944400A patent/IL149444A0/xx active IP Right Grant
- 2000-12-01 CN CNA2004100787367A patent/CN1615879A/zh active Pending
- 2000-12-01 CN CNA2004100787371A patent/CN1615880A/zh active Pending
- 2000-12-01 ES ES00978074T patent/ES2267586T3/es not_active Expired - Lifetime
- 2000-12-01 KR KR10-2004-7004651A patent/KR20040045028A/ko not_active Application Discontinuation
- 2000-12-01 EP EP03013533A patent/EP1344535A3/en not_active Withdrawn
- 2000-12-01 CZ CZ20021829A patent/CZ20021829A3/cs unknown
- 2000-12-01 EP EP00978074A patent/EP1234582B1/en not_active Expired - Lifetime
- 2000-12-01 NZ NZ518930A patent/NZ518930A/en unknown
- 2000-12-01 EP EP03013532A patent/EP1344534A3/en not_active Withdrawn
- 2000-12-01 AU AU15575/01A patent/AU773110B2/en not_active Ceased
- 2000-12-01 BR BR0015980-8A patent/BR0015980A/pt not_active IP Right Cessation
- 2000-12-01 MX MXPA02005505A patent/MXPA02005505A/es active IP Right Grant
- 2000-12-01 KR KR1020027006605A patent/KR100607430B1/ko not_active IP Right Cessation
- 2000-12-01 RU RU2002114335/15A patent/RU2002114335A/ru unknown
- 2000-12-01 HU HU0204049A patent/HUP0204049A3/hu unknown
- 2000-12-01 CA CA002392804A patent/CA2392804C/en not_active Expired - Fee Related
-
2002
- 2002-05-02 IL IL149444A patent/IL149444A/en not_active IP Right Cessation
- 2002-05-16 US US10/146,747 patent/US7307096B2/en not_active Expired - Fee Related
- 2002-05-31 NO NO20022584A patent/NO20022584L/no not_active Application Discontinuation
- 2002-12-05 HK HK02108841.2A patent/HK1047239B/zh not_active IP Right Cessation
-
2004
- 2004-04-13 RU RU2004111359/15A patent/RU2004111359A/ru not_active Application Discontinuation
- 2004-04-13 RU RU2004111358/15A patent/RU2004111358A/ru not_active Application Discontinuation
- 2004-04-13 RU RU2004111357/15A patent/RU2299067C2/ru not_active IP Right Cessation
- 2004-08-10 US US10/916,052 patent/US20050043383A1/en not_active Abandoned
- 2004-08-10 US US10/915,855 patent/US20050014808A1/en not_active Abandoned
-
2007
- 2007-10-23 US US11/977,103 patent/US20080221184A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2004111357A (ru) | Комбинированные агенты для лечения глаукомы | |
ES2235158T3 (es) | Utilizacion de fluprostenol isopropil ester para el tratamiento del glaucoma y de la hipertension ocular. | |
JP4934653B2 (ja) | Rhoキナーゼ阻害剤とβ遮断薬からなる緑内障治療剤 | |
JP2009298808A (ja) | Rhoキナーゼ阻害剤とプロスタグランジン類からなる緑内障治療剤 | |
JP2004532870A (ja) | 降圧脂質(プロスタグランジン誘導体)およびチモロールの組成物ならびにその使用方法 | |
RU2002117649A (ru) | Фармацевтические композиции, содержащие золмитриптан | |
JP2005526092A (ja) | 緑内障および眼圧亢進を治療するためのプロスタグランジンF2α類縁体およびそれらの抗菌タンパク質との併用法 | |
RU99113446A (ru) | Гуанидильные гетероциклические соединения, применяемые в качестве агонистов альфа-2 адренорецепторов | |
ES2210018T3 (es) | Antagonistas de 5ht-2 para regular la presion intraocular y tratar el glaucoma. | |
JP2002521333A (ja) | 高眼圧治療用眼薬組成物 | |
JP2005511764A (ja) | 緑内障の処置のためのアミノアルキルベンゾフラン−5−オール化合物 | |
CA2474703C (en) | Therapeutic agent of glaucoma comprising bunazosin and prostaglandins | |
RU2003104017A (ru) | Ингибиторы тромбина, содержащие аминоизохинолиновую группу | |
RU2488398C2 (ru) | Фармацевтическая комбинация опиоида и простагландинового соединения | |
RU2227740C2 (ru) | Композиции, снижающие внутриглазное давление, для местного применения | |
SE9401087D0 (sv) | New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension | |
JP4300347B2 (ja) | ブナゾシンとプロスタグランジン類からなる緑内障治療剤 | |
TWI809021B (zh) | 含有FP促效藥及β阻斷藥的青光眼治療劑 | |
EP0795331B1 (en) | Ocular depressor | |
RU2004129767A (ru) | Хинолиновые производные | |
RU2004102398A (ru) | Производные бензо[g]хинолина для лечения глаукомы и близорукости | |
JPH09507229A (ja) | 7−[カルボキシアルキルまたはアルケニル]−6−[アルキルまたはアルケニル]−3−オキソ−2,4−ジオキソビシクロ[3.2.1]オクタンおよびその誘導体 | |
AU2012236850A1 (en) | S1P antagonists as adjunct ocular hypotensives | |
JP2006021998A (ja) | Ep2アゴニストを有効成分とする月経困難症治療剤 | |
DE69829227D1 (de) | Arzneimittelzusammenstellung zur behandlung des erhöhten augeninnendrucks oder des glaukom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20091202 |